Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Cannabigerol (CBG) on Mood and Cognition
NCT05257044Phase 1Completed
- Sponsor
- Washington State University
- Start
- Mar 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing CBG with Placebo (2 arms). Primary endpoints: Change in Mood, Change in Stress and 1 more. Started Mar 2022; status: completed.
02
Drugs
cannabigerol
Beyond the preview
Go deeper on NCT05257044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05257044.